TY - STD TI - Spondyloarthritis (Spondyloarthropathies). http://www.rchsd.org/documents/2014/02/spondyloarthritis.pdf. Accessed October 20 2014. UR - http://www.rchsd.org/documents/2014/02/spondyloarthritis.pdf ID - ref1 ER - TY - JOUR AU - Sieper, J. AU - Rudwaleit, M. AU - Baraliakos, X. AU - Brandt, J. AU - Braun, J. AU - Burgos-Vargas, R. AU - Dougados, M. AU - Hermann, K. G. AU - Landewe, R. AU - Maksymowych, W. PY - 2009 DA - 2009// TI - The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.104018 DO - 10.1136/ard.2008.104018 ID - Sieper2009 ER - TY - JOUR AU - Rudwaleit, M. AU - Landewe, R. AU - Heijde, D. AU - Listing, J. AU - Brandt, J. AU - Braun, J. AU - Burgos-Vargas, R. AU - Collantes-Estevez, E. AU - Davis, J. AU - Dijkmans, B. PY - 2009 DA - 2009// TI - The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2009.108217 DO - 10.1136/ard.2009.108217 ID - Rudwaleit2009 ER - TY - JOUR AU - Rudwaleit, M. AU - Heijde, D. AU - Landewe, R. AU - Akkoc, N. AU - Brandt, J. AU - Chou, C. T. AU - Dougados, M. AU - Huang, F. AU - Gu, J. AU - Kirazli, Y. PY - 2011 DA - 2011// TI - The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.133645 DO - 10.1136/ard.2010.133645 ID - Rudwaleit2011 ER - TY - JOUR AU - Cantini, F. AU - Niccoli, L. AU - Nannini, C. AU - Kaloudi, O. AU - Bertoni, M. AU - Cassara, E. PY - 2010 DA - 2010// TI - Psoriatic arthritis: a systematic review JO - Int J Rheum Dis VL - 13 UR - https://doi.org/10.1111/j.1756-185X.2010.01540.x DO - 10.1111/j.1756-185X.2010.01540.x ID - Cantini2010 ER - TY - JOUR AU - Lee, S. AU - Mendelsohn, A. AU - Sarnes, E. PY - 2010 DA - 2010// TI - The burden of psoriatic arthritis: a literature review from a global health systems perspective JO - P & T VL - 35 ID - Lee2010 ER - TY - JOUR AU - Krueger, G. G. PY - 2002 DA - 2002// TI - Clinical features of psoriatic arthritis JO - Am J Manag Care VL - 8 ID - Krueger2002 ER - TY - STD TI - About Psoriatic Arthritis. https://www.psoriasis.org/about-psoriatic-arthritis. Accessed 30 Jun 2015. UR - https://www.psoriasis.org/about-psoriatic-arthritis ID - ref8 ER - TY - JOUR AU - Naldi, L. AU - Mercuri, S. R. PY - 2010 DA - 2010// TI - Epidemiology of comorbidities in psoriasis JO - Dermatol Ther VL - 23 UR - https://doi.org/10.1111/j.1529-8019.2010.01304.x DO - 10.1111/j.1529-8019.2010.01304.x ID - Naldi2010 ER - TY - JOUR AU - Husted, J. A. AU - Thavaneswaran, A. AU - Chandran, V. AU - Eder, L. AU - Rosen, C. F. AU - Cook, R. J. AU - Gladman, D. D. PY - 2011 DA - 2011// TI - Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis JO - Arthritis Care Res VL - 63 UR - https://doi.org/10.1002/acr.20627 DO - 10.1002/acr.20627 ID - Husted2011 ER - TY - JOUR AU - Rosen, C. F. AU - Mussani, F. AU - Chandran, V. AU - Eder, L. AU - Thavaneswaran, A. AU - Gladman, D. D. PY - 2012 DA - 2012// TI - Patients with psoriatic arthritis have worse quality of life than those with psoriasis alone JO - Rheumatology VL - 51 UR - https://doi.org/10.1093/rheumatology/ker365 DO - 10.1093/rheumatology/ker365 ID - Rosen2012 ER - TY - JOUR AU - Ackermann, C. AU - Kavanaugh, A. PY - 2008 DA - 2008// TI - Economic burden of psoriatic arthritis JO - Pharmacoeconomics VL - 26 UR - https://doi.org/10.2165/00019053-200826020-00003 DO - 10.2165/00019053-200826020-00003 ID - Ackermann2008 ER - TY - JOUR AU - Menter, A. AU - Korman, N. J. AU - Elmets, C. A. AU - Feldman, S. R. AU - Gelfand, J. M. AU - Gordon, K. B. AU - Gottlieb, A. AU - Koo, J. Y. AU - Lebwohl, M. PY - 2011 DA - 2011// TI - Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions JO - J Am Acad Dermatol VL - 65 UR - https://doi.org/10.1016/j.jaad.2010.11.055 DO - 10.1016/j.jaad.2010.11.055 ID - Menter2011 ER - TY - JOUR AU - Gossec, L. AU - Smolen, J. S. AU - Gaujoux-Viala, C. AU - Ash, Z. AU - Marzo-Ortega, H. AU - Heijde, D. AU - FitzGerald, O. AU - Aletaha, D. AU - Balint, P. AU - Boumpas, D. PY - 2012 DA - 2012// TI - European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies JO - Ann Rheum Dis VL - 71 UR - https://doi.org/10.1136/annrheumdis-2011-200350 DO - 10.1136/annrheumdis-2011-200350 ID - Gossec2012 ER - TY - JOUR AU - Smolen, J. S. AU - Braun, J. AU - Dougados, M. AU - Emery, P. AU - Fitzgerald, O. AU - Helliwell, P. AU - Kavanaugh, A. AU - Kvien, T. K. AU - Landewe, R. AU - Luger, T. PY - 2014 DA - 2014// TI - Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-203419 DO - 10.1136/annrheumdis-2013-203419 ID - Smolen2014 ER - TY - JOUR AU - Coates, L. C. PY - 2015 DA - 2015// TI - Treating to target in psoriatic arthritis JO - Curr Opin Rheumatol VL - 27 UR - https://doi.org/10.1097/BOR.0000000000000140 DO - 10.1097/BOR.0000000000000140 ID - Coates2015 ER - TY - JOUR AU - Day, M. S. AU - Nam, D. AU - Goodman, S. AU - Su, E. P. AU - Figgie, M. PY - 2012 DA - 2012// TI - Psoriatic arthritis JO - J Am Acad Orthop Surg VL - 20 ID - Day2012 ER - TY - STD TI - HUMIRA (adalimumab) Prescribing Information. http://www.rxabbvie.com/pdf/humira.pdf Accessed July 15 2015. UR - http://www.rxabbvie.com/pdf/humira.pdf ID - ref18 ER - TY - STD TI - Enbrel® (etanercept) Prescribing Information. http://pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf. Accessed 30 Jun 2015. UR - http://pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pdf ID - ref19 ER - TY - STD TI - SIMPONI (golimumab) prescribing informatiion. http://www.simponi.com/shared/product/simponi/prescribing-information.pdf. Accessed 18 Nov 2014. UR - http://www.simponi.com/shared/product/simponi/prescribing-information.pdf ID - ref20 ER - TY - STD TI - Remicade (infliximab) Prescribing Information. https://www.remicade.com/shared/product/remicade/prescribing-information.pdf. Accessed 30 Jun 2015. UR - https://www.remicade.com/shared/product/remicade/prescribing-information.pdf ID - ref21 ER - TY - STD TI - CIMZIA (certolizumab pegol) Prescribing Information. http://www.cimzia.com/assets/pdf/Prescribing_Information.pdf. Accessed 27 Jul 2015. UR - http://www.cimzia.com/assets/pdf/Prescribing_Information.pdf ID - ref22 ER - TY - STD TI - STELARA (ustekinumab). Prescribing information. http://www.stelarainfo.com/. Accessed 27 Jul 2015. UR - http://www.stelarainfo.com/ ID - ref23 ER - TY - JOUR AU - Mease, P. PY - 2013 DA - 2013// TI - Psoriatic arthritis and spondyloarthritis assessment and management update JO - Curr Opin Rheumatol VL - 25 UR - https://doi.org/10.1097/BOR.0b013e32835fd8d5 DO - 10.1097/BOR.0b013e32835fd8d5 ID - Mease2013 ER - TY - STD TI - Ogdie-Beatty AR (2015) GRAPPA initiatives continue to chart the way for psoriasis, psoriatic arthritis. PM360-Rheumatology. http://www.pm360online.com/grappa-initiatives-continue-to-chart-the-way-for-psoriasis-psoriatic-arthritis/. Accessed 30 Jun 2015. UR - http://www.pm360online.com/grappa-initiatives-continue-to-chart-the-way-for-psoriasis-psoriatic-arthritis/ ID - ref25 ER - TY - JOUR AU - Nash, P. AU - Lubrano, E. AU - Cauli, A. AU - Taylor, W. J. AU - Olivieri, I. AU - Gladman, D. D. PY - 2014 DA - 2014// TI - Updated guidelines for the management of axial disease in psoriatic arthritis JO - J Rheumatol VL - 41 UR - https://doi.org/10.3899/jrheum.140877 DO - 10.3899/jrheum.140877 ID - Nash2014 ER - TY - JOUR AU - Felquer, M. L. AU - Soriano, E. R. PY - 2015 DA - 2015// TI - New treatment paradigms in psoriatic arthritis: an update on new therapeutics approved by the U.S. Food and Drug Administration JO - Curr Opin Rheumatol VL - 27 UR - https://doi.org/10.1097/BOR.0000000000000151 DO - 10.1097/BOR.0000000000000151 ID - Felquer2015 ER - TY - JOUR AU - Fagerli, K. M. AU - Lie, E. AU - Heijde, D. AU - Heiberg, M. S. AU - Lexberg, A. S. AU - Rodevand, E. AU - Kalstad, S. AU - Mikkelsen, K. AU - Kvien, T. K. PY - 2014 DA - 2014// TI - The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2012-202347 DO - 10.1136/annrheumdis-2012-202347 ID - Fagerli2014 ER - TY - JOUR AU - Coates, L. C. AU - Kavanaugh, A. F. AU - Mease, P. J. AU - Ritchlin, C. T. PY - 2015 DA - 2015// TI - GRAPPA Treatment Recommendations: An Update from the GRAPPA 2014 Annual Meeting and GRAPPA Meeting Adjacent to the 2014 ACR Meeting JO - J Rheumatol VL - 42 UR - https://doi.org/10.3899/jrheum.150132 DO - 10.3899/jrheum.150132 ID - Coates2015 ER - TY - JOUR AU - Coates, L. C. AU - Ritchlin, C. T. AU - Kavanaugh, A. F. PY - 2014 DA - 2014// TI - GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting JO - J Rheumatol VL - 41 UR - https://doi.org/10.3899/jrheum.140179 DO - 10.3899/jrheum.140179 ID - Coates2014 ER - TY - JOUR AU - Zhang, H. F. AU - Gauthier, G. AU - Hiscock, R. AU - Curtis, J. R. PY - 2014 DA - 2014// TI - Treatment patterns in psoriatic arthritis patients newly initiated on oral nonbiologic or biologic disease-modifying antirheumatic drugs JO - Arthritis Res Ther VL - 16 UR - https://doi.org/10.1186/s13075-014-0420-5 DO - 10.1186/s13075-014-0420-5 ID - Zhang2014 ER - TY - JOUR AU - Zhu, B. AU - Edson-Heredia, E. AU - Gatz, J. L. AU - Guo, J. AU - Shuler, C. L. PY - 2013 DA - 2013// TI - Treatment patterns and health care costs for patients with psoriatic arthritis on biologic therapy: a retrospective cohort study JO - Clin Ther VL - 35 UR - https://doi.org/10.1016/j.clinthera.2013.07.328 DO - 10.1016/j.clinthera.2013.07.328 ID - Zhu2013 ER - TY - JOUR AU - Yeaw, J. AU - Watson, C. AU - Fox, K. M. AU - Schabert, V. F. AU - Goodman, S. AU - Gandra, S. R. PY - 2014 DA - 2014// TI - Treatment patterns following discontinuation of adalimumab, etanercept, and infliximab in a US managed care sample JO - Adv Ther VL - 31 UR - https://doi.org/10.1007/s12325-014-0110-3 DO - 10.1007/s12325-014-0110-3 ID - Yeaw2014 ER - TY - JOUR AU - Bonafede, M. AU - Fox, K. M. AU - Watson, C. AU - Princic, N. AU - Gandra, S. R. PY - 2012 DA - 2012// TI - Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settings JO - Adv Ther VL - 29 UR - https://doi.org/10.1007/s12325-012-0037-5 DO - 10.1007/s12325-012-0037-5 ID - Bonafede2012 ER - TY - JOUR AU - Howe, A. AU - Eyck, L. T. AU - Dufour, R. AU - Shah, N. AU - Harrison, D. J. PY - 2014 DA - 2014// TI - Treatment patterns and annual drug costs of biologic therapies across indications from the Humana commercial database JO - J Manag Care Spec Pharm VL - 20 ID - Howe2014 ER - TY - JOUR AU - Ogdie, A. AU - Schwartzman, S. AU - Husni, M. E. PY - 2015 DA - 2015// TI - Recognizing and managing comorbidities in psoriatic arthritis JO - Curr Opin Rheumatol VL - 27 UR - https://doi.org/10.1097/BOR.0000000000000152 DO - 10.1097/BOR.0000000000000152 ID - Ogdie2015 ER - TY - JOUR AU - Helliwell, P. S. AU - FitzGerald, O. AU - Fransen, J. AU - Gladman, D. D. AU - Kreuger, G. G. AU - Callis-Duffin, K. AU - McHugh, N. AU - Mease, P. J. AU - Strand, V. AU - Waxman, R. PY - 2013 DA - 2013// TI - The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201341 DO - 10.1136/annrheumdis-2012-201341 ID - Helliwell2013 ER - TY - JOUR AU - Schabert, V. F. AU - Watson, C. AU - Joseph, G. J. AU - Iversen, P. AU - Burudpakdee, C. AU - Harrison, D. J. PY - 2013 DA - 2013// TI - Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population JO - J Manag Care Pharm VL - 19 ID - Schabert2013 ER - TY - JOUR AU - Wu, N. AU - Lee, Y. C. AU - Shah, N. AU - Harrison, D. J. PY - 2014 DA - 2014// TI - Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study JO - Clin Ther VL - 36 UR - https://doi.org/10.1016/j.clinthera.2014.06.014 DO - 10.1016/j.clinthera.2014.06.014 ID - Wu2014 ER - TY - JOUR AU - Bonafede, M. AU - Joseph, G. J. AU - Princic, N. AU - Harrison, D. J. PY - 2013 DA - 2013// TI - Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis JO - J Med Econ VL - 16 UR - https://doi.org/10.3111/13696998.2013.820192 DO - 10.3111/13696998.2013.820192 ID - Bonafede2013 ER - TY - STD TI - Danielson E: Health Research Data for the Real World: The MarketScan® Databases (White Paper). 2014. ID - ref41 ER - TY - STD TI - B.R.I.D.G.E. to data. MarketScan Commercial Claims Encounters (USA). http://www.bridgetodata.org/node/987. Accessed 15 Jun 2015. UR - http://www.bridgetodata.org/node/987 ID - ref42 ER - TY - STD TI - (2012) Truven Health Analytics [homepage on the Internet]. http://truvenhealth.com/your_healthcare_focus/research/marketscan_research_databases.aspx. Accessed 11 Oct 2014. UR - http://truvenhealth.com/your_healthcare_focus/research/marketscan_research_databases.aspx ID - ref43 ER - TY - STD TI - Palmer JB, LI Y, Tsang Y, Liao M, Ozturk Z: Treatment patterns and costs for anti-TNFα therapy in patients with ankylosing spondylitis. Rheumatology (Sunnyvale) 2015, (in press). ID - ref44 ER - TY - STD TI - Imuran (azathioprine) Prescribing Information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016324s034s035lbl.pdf. Accessed 15 Jun 2015. UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/016324s034s035lbl.pdf ID - ref45 ER - TY - STD TI - PLAQUENIL (hydroxychloroquine sulfate) Prescribing Information. http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf. Accessed 30 Jun 2015. UR - http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/009768s041lbl.pdf ID - ref46 ER - TY - STD TI - ARAVA® (leflunomide) Prescribing Information. http://products.sanofi.com.au/aus_pi_arava.pdf. Accessed 30 Jun 2015. UR - http://products.sanofi.com.au/aus_pi_arava.pdf ID - ref47 ER - TY - STD TI - Azulfidine® (sulfasalazine) Prescribing Information. http://labeling.pfizer.com/ShowLabeling.aspx?id=524. Accessed 30 Jun 2015. UR - http://labeling.pfizer.com/ShowLabeling.aspx?id=524 ID - ref48 ER - TY - STD TI - Sandimmune® (cyclosporine) Prescribing Information. https://www.pharma.us.novartis.com/product/pi/pdf/sandimmune.pdf. Accessed 30 Jun 2015. UR - https://www.pharma.us.novartis.com/product/pi/pdf/sandimmune.pdf ID - ref49 ER - TY - STD TI - Methotrexate (Product Monograph). http://www.pfizer.ca/sites/g/files/g10017036/f/201410/Methotrexate_0.pdf. Accessed 30 Jun 2015. UR - http://www.pfizer.ca/sites/g/files/g10017036/f/201410/Methotrexate_0.pdf ID - ref50 ER - TY - STD TI - OTEZLA® (apremilast) Prescribing Information. http://www.otezlapro.com/wp-content/uploads/2015/02/otezla-prescribing-information.pdf. Accessed 30 Jun 2015. UR - http://www.otezlapro.com/wp-content/uploads/2015/02/otezla-prescribing-information.pdf ID - ref51 ER - TY - JOUR AU - Glintborg, B. AU - Ostergaard, M. AU - Krogh, N. S. AU - Andersen, M. D. AU - Tarp, U. AU - Loft, A. G. AU - Lindegaard, H. M. AU - Holland-Fischer, M. AU - Nordin, H. AU - Jensen, D. V. PY - 2013 DA - 2013// TI - Clinical response, drug survival, and predictors thereof among 548 patients with psoriatic arthritis who switched tumor necrosis factor alpha inhibitor therapy: results from the Danish Nationwide DANBIO Registry JO - Arthritis Rheum VL - 65 UR - https://doi.org/10.1002/art.37876 DO - 10.1002/art.37876 ID - Glintborg2013 ER - TY - JOUR AU - Glintborg, B. AU - Ostergaard, M. AU - Dreyer, L. AU - Krogh, N. S. AU - Tarp, U. AU - Hansen, M. S. AU - Rifbjerg-Madsen, S. AU - Lorenzen, T. AU - Hetland, M. L. PY - 2011 DA - 2011// TI - Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti-tumor necrosis factor alpha therapy: results from the nationwide Danish DANBIO registry JO - Arthritis Rheum VL - 63 UR - https://doi.org/10.1002/art.30117 DO - 10.1002/art.30117 ID - Glintborg2011 ER - TY - JOUR AU - Heiberg, M. S. AU - Koldingsnes, W. AU - Mikkelsen, K. AU - Rodevand, E. AU - Kaufmann, C. AU - Mowinckel, P. AU - Kvien, T. K. PY - 2008 DA - 2008// TI - The comparative one-year performance of anti-tumor necrosis factor alpha drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: results from a longitudinal, observational, multicenter study JO - Arthritis Rheum VL - 59 UR - https://doi.org/10.1002/art.23333 DO - 10.1002/art.23333 ID - Heiberg2008 ER - TY - JOUR AU - Glintborg, B. AU - Ostergaard, M. AU - Krogh, N. S. AU - Tarp, U. AU - Manilo, N. AU - Loft, A. G. AU - Hansen, A. AU - Schlemmer, A. AU - Fana, V. AU - Lindegaard, H. M. PY - 2013 DA - 2013// TI - Clinical response, drug survival and predictors thereof in 432 ankylosing spondylitis patients after switching tumour necrosis factor alpha inhibitor therapy: results from the Danish nationwide DANBIO registry JO - Ann Rheum Dis VL - 72 UR - https://doi.org/10.1136/annrheumdis-2012-201933 DO - 10.1136/annrheumdis-2012-201933 ID - Glintborg2013 ER - TY - JOUR AU - Fabbroni, M. AU - Cantarini, L. AU - Caso, F. AU - Costa, L. AU - Pagano, V. A. AU - Frediani, B. AU - Manganelli, S. AU - Galeazzi, M. PY - 2014 DA - 2014// TI - Drug retention rates and treatment discontinuation among anti-TNF-alpha agents in psoriatic arthritis and ankylosing spondylitis in clinical practice JO - Mediators Inflamm VL - 2014 UR - https://doi.org/10.1155/2014/862969 DO - 10.1155/2014/862969 ID - Fabbroni2014 ER -